Search results
AHN Honors Neurosciences
Erie News Now Plus· 16 hours agoThe event featured music, dinner and charity auctions, with the money raised benefiting neurosciences at the hospital.
Bet on it: Handicapper John Murges isn’t letting Parkinson’s keep him down
Chicago Sun-Times· 13 hours agoAt home last fall in Sarasota, Florida, a few fingers trembled as John Murges went 5-0 against the...
Alto Neuroscience schizophrenia treatment shows good phase 1 results
Seeking Alpha· 4 days agoALTO-101, a PDE4 inhibitor by Alto Neuroscience, shows promising results in phase 1 trial for...
New Haven and neuroscience: Match made in heaven?
Hartford Business Journal· 2 days agoThe announcement last spring by Yale New Haven Health of plans to develop an $838 million neurosciences facility on its St. Raphael campus marked New...
▶️ Listen Now: The benefits of teaching kids about neuroscience
WBEZ 91.5 Chicago· 4 days agoWhen people are science literate, they could be more health literate too.
Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In...
Benzinga via Yahoo Finance· 4 days agoRecently listed Alto Neuroscience Inc (NYSE:ANRO) released results from its healthy volunteer Phase...
Alto Neuroscience reports positive Phase 1 results for ALTO-101 By Investing.com
Investing.com· 4 days agoAlto Neuroscience, Inc. (NYSE: ANRO) announced today that its Phase 1 study of ALTO-101, a novel...
To be better at neuroscience, Biogen will invest outside the therapeutic area
FierceBiotech· 3 days agoTo be a better neuroscience company, Biogen is going to have to diversify—outside of the therapeutic...
...Renowned Neurosurgeon Dr. Adam Kanter as Executive Medical Director of its Nationally Ranked...
CW39 NewsFix· 5 days agoHoag announced today Adam Kanter, M.D., F.A.A.N.S, has been named Executive Medical Director of the Pickup Family Neurosciences Institute. Dr. Kanter will lead a multidisciplinary ...
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical...
Morningstar· 4 days ago...Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug Research (CHDR), will present its Phase 1 stroke...